<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.dermatologytimes.com/view/tanprevent-and-the-case-for-preventing-thousands-of-melanomas</loc>
      <lastmod>2026-11-18T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T14:00:00Z</news:publication_date>
        <news:title><![CDATA[TanPrevent and the Case for Preventing Thousands of Melanomas]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/provocation-testing-for-cindu-bringing-trial-tools-into-clinical-practice</loc>
      <lastmod>2026-11-18T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Provocation Testing for CIndU: Bringing Trial Tools Into Clinical Practice]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/cindu-patient-demographics-disease-duration-diagnostic-delay-and-quality-of-life</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[CIndU Patient Demographics: Disease Duration, Diagnostic Delay, and Quality of Life]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/bioelements-and-celluma-collaborate-on-led-facial-treatments</loc>
      <lastmod>2026-11-17T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Bioelements and Celluma Collaborate on LED Facial Treatments]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/alopecia-areata-patient-advice-treatment-decisions-choosing-a-specialist-and-self-advocacy</loc>
      <lastmod>2026-11-17T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Alopecia Areata Patient Advice: Treatment Decisions, Choosing a Specialist, and Self-Advocacy]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/interpreting-gep-results-in-melanoma-limitations-and-patient-centered-care</loc>
      <lastmod>2026-11-17T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Interpreting GEP Results in Melanoma: Limitations and Patient-Centered Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/monitoring-and-treatment-selection-for-oral-tyk2-inhibitors-in-psoriasis</loc>
      <lastmod>2026-11-16T20:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Monitoring and Treatment Selection for Oral TYK2 Inhibitors in Psoriasis]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/fda-implements-updated-ipledge-rems-requirements-for-isotretinoin</loc>
      <lastmod>2026-11-16T19:49:32.572Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T19:49:32.572Z</news:publication_date>
        <news:title><![CDATA[FDA Implements Updated iPLEDGE REMS Requirements for Isotretinoin]]></news:title>
      </news:news>
	</url></urlset>